You are here: Home » Current Affairs » News » National
Business Standard

India drug regulator meets to discuss AstraZeneca vaccine: Report

SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people

Serum Institute of India | Coronavirus Vaccine | AstraZeneca

Reuters  |  NEW DELHI 

Experts at India's drug regulator were meeting on Wednesday to consider approving an AstraZeneca/Oxford coronavirus vaccine for emergency use after Britain became the first country to do so, two sources with knowledge of the matter said. A representative of India's Central Drugs Standard Control Organization (CDSCO) declined to reveal the agenda of the meeting but said its minutes would be uploaded on its website within hours. Sources earlier told Reuters the CDSCO was likely to approve the vaccine this week after its local manufacturer, Serum Institute of India (SII), ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, December 30 2020. 18:21 IST